The Plk1 inhibitor BI 2536 in patients with refractory or relapsed non-Hodgkin lymphoma: a phase I, open-label, single dose-escalation study
Vose, Julie M., Friedberg, Jonathan W., Waller, Edmund K., Cheson, Bruce D., Juvvigunta, Vasthala, Fritsch, Holger, Petit, Claude, Munzert, Gerd, Younes, AnasVolume:
54
Language:
english
Journal:
Leukemia & Lymphoma
DOI:
10.3109/10428194.2012.729833
Date:
April, 2013
File:
PDF, 266 KB
english, 2013